BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20498617)

  • 41. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells.
    Inagaki K; Otsuka F; Suzuki J; Kano Y; Takeda M; Miyoshi T; Otani H; Mimura Y; Ogura T; Makino H
    Endocrinology; 2006 Jun; 147(6):2681-9. PubMed ID: 16527843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression.
    Lesouhaitier O; Chiappe A; Rossier MF
    Endocrinology; 2001 Oct; 142(10):4320-30. PubMed ID: 11564691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin II-induced expression of brain-derived neurotrophic factor in human and rat adrenocortical cells.
    Szekeres M; Nádasy GL; Turu G; Süpeki K; Szidonya L; Buday L; Chaplin T; Clark AJ; Hunyady L
    Endocrinology; 2010 Apr; 151(4):1695-703. PubMed ID: 20181798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?
    Barter P; Rye KA
    Trends Pharmacol Sci; 2011 Dec; 32(12):694-9. PubMed ID: 22088767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on CETP inhibition.
    Davidson MH
    J Clin Lipidol; 2010; 4(5):394-8. PubMed ID: 21122682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.
    Saha S; Bornstein SR; Graessler J; Kopprasch S
    Cell Tissue Res; 2012 Apr; 348(1):71-80. PubMed ID: 22331364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.
    Jansen PM; Hofland J; van den Meiracker AH; de Jong FH; Danser AH
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):360-6. PubMed ID: 22396488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of CETP inhibition.
    Duivenvoorden R; Fayad ZA
    Curr Opin Lipidol; 2012 Dec; 23(6):518-24. PubMed ID: 23010697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QRFP induces aldosterone production via PKC and T-type calcium channel-mediated pathways in human adrenocortical cells: evidence for a novel role of GPR103.
    Ramanjaneya M; Karteris E; Chen J; Rucinski M; Ziolkowska A; Ahmed N; Kagerer S; Jöhren O; Lehnert H; Malendowicz LK; Randeva HS
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1049-58. PubMed ID: 23964068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.
    Sofat R; Hingorani AD; Smeeth L; Humphries SE; Talmud PJ; Cooper J; Shah T; Sandhu MS; Ricketts SL; Boekholdt SM; Wareham N; Khaw KT; Kumari M; Kivimaki M; Marmot M; Asselbergs FW; van der Harst P; Dullaart RP; Navis G; van Veldhuisen DJ; Van Gilst WH; Thompson JF; McCaskie P; Palmer LJ; Arca M; Quagliarini F; Gaudio C; Cambien F; Nicaud V; Poirer O; Gudnason V; Isaacs A; Witteman JC; van Duijn CM; Pencina M; Vasan RS; D'Agostino RB; Ordovas J; Li TY; Kakko S; Kauma H; Savolainen MJ; Kesäniemi YA; Sandhofer A; Paulweber B; Sorli JV; Goto A; Yokoyama S; Okumura K; Horne BD; Packard C; Freeman D; Ford I; Sattar N; McCormack V; Lawlor DA; Ebrahim S; Smith GD; Kastelein JJ; Deanfield J; Casas JP
    Circulation; 2010 Jan; 121(1):52-62. PubMed ID: 20026784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells.
    Szekeres M; Turu G; Orient A; Szalai B; Süpeki K; Cserzo M; Várnai P; Hunyady L
    Mol Cell Endocrinol; 2009 Apr; 302(2):244-53. PubMed ID: 19418629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.
    Cao G; Beyer TP; Zhang Y; Schmidt RJ; Chen YQ; Cockerham SL; Zimmerman KM; Karathanasis SK; Cannady EA; Fields T; Mantlo NB
    J Lipid Res; 2011 Dec; 52(12):2169-2176. PubMed ID: 21957197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical characterization of cholesteryl ester transfer protein inhibitors.
    Ranalletta M; Bierilo KK; Chen Y; Milot D; Chen Q; Tung E; Houde C; Elowe NH; Garcia-Calvo M; Porter G; Eveland S; Frantz-Wattley B; Kavana M; Addona G; Sinclair P; Sparrow C; O'Neill EA; Koblan KS; Sitlani A; Hubbard B; Fisher TS
    J Lipid Res; 2010 Sep; 51(9):2739-52. PubMed ID: 20458119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.
    Ye P; Nakamura Y; Lalli E; Rainey WE
    Endocrinology; 2009 Mar; 150(3):1303-9. PubMed ID: 18974272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The failure of torcetrapib: what have we learned?
    Joy TR; Hegele RA
    Br J Pharmacol; 2008 Aug; 154(7):1379-81. PubMed ID: 18536741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
    Aritomi S; Konda T; Yoshimura M
    Heart Vessels; 2012 Jul; 27(4):419-23. PubMed ID: 21989861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production.
    Pezzi V; Clark BJ; Ando S; Stocco DM; Rainey WE
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):417-24. PubMed ID: 8903426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells.
    Liang F; Kapoun AM; Lam A; Damm DL; Quan D; O'Connell M; Protter AA
    Endocrinology; 2007 Aug; 148(8):3722-9. PubMed ID: 17478552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.